Revolution Medicines, Inc.

RVMD Net selling

CIK 0001628171 #590 in the set updated 17 Sep 2026

Bought (120 mo)

$134.50M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$434.22M

$36.22M on a plan · $165.93M straight out of an exercise

Sold at will

$232.07M

95 of 438 sales

Net

−$299.72M

−$97.57M against sales at will

By person

26 insiders · 489 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Schroeder Thilo

Director

$123.30M (37)

—

+$123.30M

760,869

0.3550%

$156.59M

—

Svennilson Peter

Director

—

$84.23M (18)

−$84.23M

1,795,538

0.8377%

$369.54M

−64.3%

GOLDSMITH MARK A

See Remarks

—

$78.28M (121) scheduled

−$78.28M

328,754

0.1534%

$67.66M

+23.7%

COLUMN GROUP III, LP entity

10% owner

—

$73.79M (2)

−$73.79M

4,580,206

2.14%

$942.64M

—

Third Rock Ventures II, L.P. entity

10% owner

—

$58.17M (4)

−$58.17M

0

0.0000%

$0.00

−100.0%

Kelsey Stephen Michael

See Remarks

—

$39.23M (82) scheduled

−$39.23M

291,876

0.1362%

$60.07M

+6.2%

Horn Margaret A

Chief Operating Officer

—

$36.84M (53) scheduled

−$36.84M

154,647

0.0722%

$31.83M

+10.1%

Cislini Jeff

General Counsel

—

$16.59M (41) scheduled

−$16.59M

55,907

0.0261%

$11.51M

+18.2%

Kim Lorence H.

Director

$1.00M (1)

$14.97M (14) scheduled

−$13.97M

1,191

0.0006%

$245.12K

—

Flynn James E

10% owner

$10.20M (2)

—

+$10.20M

798,795

0.3727%

$164.40M

—

Anders Jack

Chief Financial Officer

—

$9.95M (35) scheduled

−$9.95M

123,269

0.0575%

$25.37M

+1,828%

Third Rock Ventures III, L.P. entity

10% owner

—

$8.50M (1)

−$8.50M

5,104,130

2.38%

$1.05B

—

Mancini Anthony

See Remarks

—

$8.35M (17) scheduled

−$8.35M

43,890

0.0205%

$9.03M

−19.6%

Weber Barbara

Director

—

$1.90M (12) scheduled

−$1.90M

13,065

0.0061%

$2.69M

—

Patel Sushil

Director

—

$1.49M (12) scheduled

−$1.49M

21,656

0.0101%

$4.46M

—

Miller Vincent A.

Director

—

$613.66K (5)

−$613.66K

23,750

0.0111%

$4.89M

−23.0%

Wei Lin

Chief Medical Officer

—

$600.71K (4) scheduled

−$600.71K

101,366

0.0473%

$20.86M

−14.9%

ANDERSON ELIZABETH M

Director

—

$425.00K (3)

−$425.00K

24,406

0.0114%

$5.02M

+158.3%

Wang Xiaolin

See Remarks

—

$284.08K (9) scheduled

−$284.08K

116,063

0.0541%

$23.89M

+1,802%

Exter Neil

Director

—

— (5)

$0.00

28,815

0.0134%

$5.93M

+44.1%

Borisy Alexis

Director

—

—

—

2,340,075

1.09%

$481.60M

+947.3%

Third Rock Ventures IV, L.P. entity

10% owner

—

—

—

1,419,900

0.6625%

$292.23M

—

Horning Sandra

Director

—

—

—

97,765

0.0456%

$20.12M

—

Borellini Flavia

Director

—

—

—

26,215

0.0122%

$5.40M

—

SCHMIDT ERIC THOMAS

Director

—

—

—

21,251

0.0099%

$4.37M

—

Clyburn Frank

Director

—

—

—

10,929

0.0051%

$2.25M

—

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Mancini Anthony

16 Jun 2026

See Remarks

Sell

4,615

$156.12

$720.49K

Wei Lin

17 Jun 2024

Chief Medical Officer

Sell

5,589

$37.39

$208.95K

Showing 250 of 489 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 360

Amendments (4/A) skipped 9

Filings about a different issuer 0

Unreadable filings 0

Joint filings 12

Sales on a Rule 10b5-1 plan 102

Sales straight out of an exercise 241

Sales at will 95

Transactions with no price 0

Shares from compensation/vesting 35,846,807

Sales filed before the plan box existed 81

History held since 14 Feb 2020